Device / Technology News

RSS

LifeCodexx AG develops test using Next Generation Sequencing technologies for prenatal diagnostics

LifeCodexx AG has started operational research and development work on clinically validated diagnostic tests by using Next Generation Sequencing technologies. The work currently focuses on the field of prenatal diagnostics.

12 May 2010

Group worries about proposals to allow drug marketing on social media websites

The Center for Digital Democracy is concerned about proposals to allow pharmaceutical companies to market drugs on social media websites. Such a change is under examination by the Food and Drug Administration, the National Journal's Tech Daily Dose reports.

12 May 2010

CEA-Leti launches TARGET-PDT project to increase effectiveness of PDT for treating cancer

CEA-Leti today announced the launch of the TARGET-PDT project designed to increase the effectiveness of photodynamic therapy for treating cancer by developing a novel nano carrier-based approach.

12 May 2010

SonarMed AMS technology obtains FDA clearance

SonarMed, a developer and manufacturer of critical care respiratory monitoring technologies, announced that it has received Food and Drug Administration clearance for its patented SonarMed Airway Monitoring System, which monitors breathing tubes for patients requiring ventilators.

12 May 2010

MaxCyte STX Scalable Transfection System acquired by CCS Cell Culture Service

MaxCyte, Inc., the pioneer in scalable, high performance cell loading systems, is pleased to announce that CCS Cell Culture Service GmbH has acquired the MaxCyte® STX™ Scalable Transfection System to develop and optimize cells for the pharmaceutical industry.

12 May 2010

FDA approves delivery of Cefepime in B. Braun's DUPLEX System

The U.S. Food and Drug Administration recently approved an application that permits B. Braun Medical Inc. (B. Braun) to deliver FDA-approved 1g and 2g Cefepime for Injection USP and Dextrose Injection USP in B. Braun's DUPLEX® Drug Delivery System.

From B. Braun Melsungen AG 12 May 2010

IMBio receives regulatory concurrence from FDA to market OCL 500 microspheres in the U.S.

IMBiotechnologies Ltd., a privately held biotechnology company focused on developing medical device products for use in the area of embolotherapy, today announced that it has received regulatory concurrence from the United States Food and Drug Administration to market its lead product, Occlusin 500 Artificial Embolization Device in the U.S. for the treatment of unresectable/inoperable hypervascularized tumours.

12 May 2010

FDA approves software upgrade to Boston Scientific's LATITUDE Patient Management system

Boston Scientific Corporation today announced U.S. Food and Drug Administration (FDA) approval for LATITUDE 6.0, a software upgrade to the Company's LATITUDE® Patient Management system. The LATITUDE system enables physicians to remotely monitor patients with implantable cardiac devices. The upgrade provides enhanced functionality, including the ability to view an expanded history of a patient's remote follow-up data.

12 May 2010

Phakic IOLs safer than laser surgery for correcting moderate short-sightedness

A new type of procedure for correcting short-sightedness could be safer than laser eye surgery, according to a new Cochrane Systematic Review. The study also shows that patients prefer the new procedure, despite there being little difference between the two in terms of improving vision.

12 May 2010

Microfluidics International first-quarter revenue up 21%

Microfluidics International Corporation, today reported unaudited financial results for the first quarter ended March 31, 2010.

11 May 2010

DNA Medicine Institute awarded Grand Challenges Explorations grant to develop finger scanner for malaria

The DNA Medicine Institute announced today that it has received a US$100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project conducted by Eugene Y. Chan, M.D. titled "Optomagnetic Finger Scanner for Malaria."

11 May 2010

$2.8 billion U.S. peripheral vascular device market to grow to over $5.3 billion by 2016

According to a new report by iData Research, the leading authority in medical device and pharmaceutical market research, the U.S. peripheral vascular device market is worth $2.8 billion with expected growth to over $5.3 billion by 2016. Increased detection and treatment of abdominal aortic aneurysms (AAAs) and peripheral arterial disease (PAD) are the main drivers of this market, particularly in the stent-graft and peripheral vascular stent segments. These markets are both expected to exceed $1 billion by 2016.

11 May 2010

Amorfix, Epitomics collaborate to develop high-affinity monoclonal antibodies against cancer targets

Amorfix Life Sciences and Epitomics, Inc. announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Amorfix has identified several disease specific epitopes (DSEs) on misfolded proteins with their proprietary ProMIS(TM) computational platform discovery technology, which will be used by Epitomics to generate highly specific monoclonal antibodies (mAbs).

11 May 2010

Viking Systems to demonstrate 3DHD Vision System prototype at Hospital Build Asia 2010

Viking Systems, Inc. today announced that a prototype version of its Next Generation 3DHD Vision System will be demonstrated with Sony's prototype 3DHD Medical Display in Sony's booth at Hospital Build Asia 2010 which will run May 11 -13 in Singapore.

11 May 2010

NeuroMetrix first-quarter total revenues decrease to $3.7 million

NeuroMetrix, Inc., a health care company transforming patient care through neurotechnology, today announced its financial results for the three months ended March 31, 2010.

11 May 2010

A.D.A.M. first-quarter license revenues increase 5% to $6.5 million

A.D.A.M., Inc., a leading provider of health information and benefit technology solutions, today announced its financial results for the first quarter ended March 31, 2010.

11 May 2010

Health Evolution Partners releases 2010 Health Industry Landscape Report

David J. Brailer, MD, PhD, Chairman of Health Evolution Partners, announced the firm's release of the 2010 Health Industry Landscape Report.

11 May 2010

BSD, ProZyme partner to redefine biotherapeutic glycan analysis workflow

BioSystem Development, LLC (BSD) and ProZyme, Inc. announce a partnership to redefine biotherapeutic glycan analysis workflow. The first product from this collaboration combines ProZyme's proprietary enzymatic N-deglycosylation, labeling and cleanup chemistry with BSD's AssayMAP™ high- throughput micro chromatography platform resulting in a rapid, quantitative N-glycan sample preparation method fully enabled for any scale of automation.

11 May 2010

Isolite Systems to launch LED Smart Stick for dryfield illuminator at "The Art & Science of Dentistry" meeting

Isolite Systems, maker of innovative dental isolation technology, will debut an even brighter, more technically advanced LED Smart Stick for its award-winning Isolite dryfield illuminator during the California Dental Association's "The Art & Science of Dentistry" scientific meeting and exhibition held May 13 -16, 2010 at the Anaheim Convention Center.

11 May 2010

New study to send microorganisms into space

A team of researchers from Rensselaer Polytechnic Institute will send an army of microorganisms into space this week, to investigate new ways of preventing the formation and spread of biofilms, or clusters of bacteria, that could pose a threat to the health of astronauts.

11 May 2010

Device / Technology News

LifeCodexx AG develops test using Next Generation Sequencing technologies for prenatal diagnostics

Group worries about proposals to allow drug marketing on social media websites

CEA-Leti launches TARGET-PDT project to increase effectiveness of PDT for treating cancer

SonarMed AMS technology obtains FDA clearance

MaxCyte STX Scalable Transfection System acquired by CCS Cell Culture Service

FDA approves delivery of Cefepime in B. Braun's DUPLEX System

IMBio receives regulatory concurrence from FDA to market OCL 500 microspheres in the U.S.

FDA approves software upgrade to Boston Scientific's LATITUDE Patient Management system

Phakic IOLs safer than laser surgery for correcting moderate short-sightedness

Microfluidics International first-quarter revenue up 21%

DNA Medicine Institute awarded Grand Challenges Explorations grant to develop finger scanner for malaria

$2.8 billion U.S. peripheral vascular device market to grow to over $5.3 billion by 2016

Amorfix, Epitomics collaborate to develop high-affinity monoclonal antibodies against cancer targets

Viking Systems to demonstrate 3DHD Vision System prototype at Hospital Build Asia 2010

NeuroMetrix first-quarter total revenues decrease to $3.7 million

A.D.A.M. first-quarter license revenues increase 5% to $6.5 million

Health Evolution Partners releases 2010 Health Industry Landscape Report

BSD, ProZyme partner to redefine biotherapeutic glycan analysis workflow

Isolite Systems to launch LED Smart Stick for dryfield illuminator at "The Art & Science of Dentistry" meeting

New study to send microorganisms into space

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News